Vicky Nicolaidou

926 total citations
29 papers, 639 citations indexed

About

Vicky Nicolaidou is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Vicky Nicolaidou has authored 29 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Vicky Nicolaidou's work include SARS-CoV-2 and COVID-19 Research (4 papers), MicroRNA in disease regulation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Vicky Nicolaidou is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), MicroRNA in disease regulation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Vicky Nicolaidou collaborates with scholars based in Cyprus, United Kingdom and United States. Vicky Nicolaidou's co-authors include Nicole J. Horwood, Andia N. Redpath, Andrew P. Cope, Adel Ersek, Dilair Baban, Lynn Williams, Mei Mei Wong, Kim S. Midwood, Costas Koufaris and Christos Papaneophytou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Vicky Nicolaidou

29 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicky Nicolaidou Cyprus 12 265 142 129 111 109 29 639
Mizuho Kittaka Japan 17 295 1.1× 134 0.9× 119 0.9× 129 1.2× 75 0.7× 35 677
Fei Kuang China 13 336 1.3× 84 0.6× 328 2.5× 105 0.9× 86 0.8× 30 822
Yannic Danger France 8 266 1.0× 94 0.7× 487 3.8× 165 1.5× 107 1.0× 19 971
Yingjie Nie China 16 291 1.1× 59 0.4× 260 2.0× 159 1.4× 55 0.5× 41 714
Alison J. Cartwright United Kingdom 15 237 0.9× 200 1.4× 102 0.8× 85 0.8× 47 0.4× 20 632
S Spinella-Jaegle France 6 521 2.0× 148 1.0× 52 0.4× 149 1.3× 81 0.7× 7 773
Jungeun Yu United States 18 406 1.5× 72 0.5× 77 0.6× 100 0.9× 54 0.5× 37 618
Assi Levi Israel 15 124 0.5× 150 1.1× 178 1.4× 199 1.8× 72 0.7× 73 882
Darja Andreev Germany 13 264 1.0× 195 1.4× 253 2.0× 141 1.3× 91 0.8× 22 690
Nhan Lu-Chinh Phan Vietnam 13 247 0.9× 163 1.1× 59 0.5× 291 2.6× 158 1.4× 26 816

Countries citing papers authored by Vicky Nicolaidou

Since Specialization
Citations

This map shows the geographic impact of Vicky Nicolaidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Nicolaidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Nicolaidou more than expected).

Fields of papers citing papers by Vicky Nicolaidou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky Nicolaidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Nicolaidou. The network helps show where Vicky Nicolaidou may publish in the future.

Co-authorship network of co-authors of Vicky Nicolaidou

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky Nicolaidou. A scholar is included among the top collaborators of Vicky Nicolaidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky Nicolaidou. Vicky Nicolaidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicolaidou, Vicky, et al.. (2024). Biochemical Characterisation of the Short Isoform of Histone N-Terminal Acetyltransferase NAA40. Biomolecules. 14(9). 1100–1100. 2 indexed citations
2.
3.
Nicolaidou, Vicky, et al.. (2024). Short-Chained Linear Scorpion Peptides: A Pool for Novel Antimicrobials. Antibiotics. 13(5). 422–422. 8 indexed citations
4.
Koufaris, Costas & Vicky Nicolaidou. (2023). Erythrocyte enucleation in mammals is an anticancer mechanism: A hypothesis. Medical Hypotheses. 181. 111207–111207. 1 indexed citations
5.
Nicolaidou, Vicky, et al.. (2023). Detection of SARS-CoV-2–Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review. International Journal of Molecular Sciences. 24(3). 2957–2957. 7 indexed citations
6.
Koufaris, Costas, et al.. (2023). miR-22-enriched breast cancer cells display repressed glycolytic metabolism, increased glycogen synthesis, and reduced survival in low glucose conditions. Molecular Biology Reports. 50(6). 5185–5193. 1 indexed citations
7.
Pieri, Myrtani, et al.. (2023). Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far. International Journal of Molecular Sciences. 24(3). 2380–2380. 10 indexed citations
8.
Vlasiou, Manos C., Vicky Nicolaidou, & Christos Papaneophytou. (2023). Targeting Lactate Dehydrogenase-B as a Strategy to Fight Cancer: Identification of Potential Inhibitors by In Silico Analysis and In Vitro Screening. Pharmaceutics. 15(10). 2411–2411. 15 indexed citations
9.
Papaneophytou, Christos, Myrtani Pieri, Vicky Nicolaidou, et al.. (2022). Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus. PLoS ONE. 17(6). e0269885–e0269885. 2 indexed citations
10.
Papaneophytou, Christos, et al.. (2022). SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level. International Journal of Medical Sciences. 19(12). 1787–1795. 6 indexed citations
11.
Koufaris, Costas & Vicky Nicolaidou. (2021). Glutamine addiction in virus-infected mammalian cells: A target of the innate immune system?. Medical Hypotheses. 153. 110620–110620. 5 indexed citations
12.
Nilsson, Roland, Vicky Nicolaidou, & Costas Koufaris. (2019). Mitochondrial MTHFD isozymes display distinct expression, regulation, and association with cancer. Gene. 716. 144032–144032. 19 indexed citations
13.
Nicolaidou, Vicky, et al.. (2018). Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis. PLoS ONE. 13(3). e0193684–e0193684. 12 indexed citations
14.
Nicolaidou, Vicky & Costas Koufaris. (2015). MicroRNA responses to environmental liver carcinogens: Biological and clinical significance. Clinica Chimica Acta. 445. 25–33. 11 indexed citations
15.
Chi, Jianxiang, Menelaos Manoloukos, Chryso Pierides, et al.. (2014). Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring. Annals of Hematology. 94(3). 399–408. 35 indexed citations
16.
Verhoekx, Jennifer S. N., Liaquat Suleman Verjee, David Izadi, et al.. (2013). Isometric Contraction of Dupuytren’s Myofibroblasts Is Inhibited by Blocking Intercellular Junctions. Journal of Investigative Dermatology. 133(12). 2664–2671. 24 indexed citations
17.
Verjee, Liaquat Suleman, Jennifer S. N. Verhoekx, James Chan, et al.. (2013). Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target. Proceedings of the National Academy of Sciences. 110(10). E928–37. 99 indexed citations
18.
Nicolaidou, Vicky, et al.. (2013). Cells of the Immune System Orchestrate Changes in Bone Cell Function. Calcified Tissue International. 94(1). 98–111. 23 indexed citations
19.
Nicolaidou, Vicky, Mei Mei Wong, Andia N. Redpath, et al.. (2012). Monocytes Induce STAT3 Activation in Human Mesenchymal Stem Cells to Promote Osteoblast Formation. PLoS ONE. 7(7). e39871–e39871. 198 indexed citations
20.
Hall, Spencer E., Allen Mao, Vicky Nicolaidou, et al.. (2009). Elucidation of Binding Sites of Dual Antagonists in the Human Chemokine Receptors CCR2 and CCR5. Molecular Pharmacology. 75(6). 1325–1336. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mizuho Kittaka Breakdown of academic impact, for papers by Fei Kuang Breakdown of academic impact, for papers by Yannic Danger Breakdown of academic impact, for papers by Yingjie Nie Breakdown of academic impact, for papers by Alison J. Cartwright Breakdown of academic impact, for papers by S Spinella-Jaegle Breakdown of academic impact, for papers by Jungeun Yu Breakdown of academic impact, for papers by Assi Levi Breakdown of academic impact, for papers by Darja Andreev Breakdown of academic impact, for papers by Nhan Lu-Chinh Phan
Rankless by CCL
2026